User Reviews
Filter reviews
Never subscrided to this letter. Subscride to S & A report so I get all the hype S & A dishes out for you to buy this expensive letter. So my comment will be limited to their “hawking” of ARNA. Such hype—-2 years of research—$200,000 spent for research—invest 5thou or 10 thou and retire. It Read more...
Hey, Rob L., Phase 1 never recommended buying ARNA! They said DON’T buy the stock, buy a call spread. They sold the spread after the announcement for a 40% loss and then recommended selling the July $2.50 put for enough money to get the loss back. But, overall, Phase 1 does not seem to “get” stock Read more...
Remember this teaser? “On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight!” Well, March 30 has arrived! The results are in! And indeed you COULD have made $195,600…if you had SHORTED Arena Pharmaceuticals instead of BUYING it, the way Phase One pounded the Read more...
Focuses on small, potential explosive growth companies, mostly in tech and biotech.
- 1